Dr. Ronald G. Nahass, President of the Infectious Diseases Society of America (IDSA) and clinical professor of medicine, recently spoke about the reaction from leading medical organizations to changes in federal vaccine guidance in an interview with Infectious Disease Special Edition.
Dr. Nahass highlighted widespread concern among clinicians after a Centers for Disease Control and Prevention (CDC) vaccine advisory panel voted to alter longstanding recommendations for universal hepatitis B vaccination at birth. He emphasized that major medical societies, including IDSA, have pushed back against this policy shift, reaffirming their support for evidence-based immunization practices and clear, science-driven guidance for clinicians and families.
“In the past, we’ve had a consistent message,” Dr. Nahass said. “Because the advisory committee is not following the evidence, not following the science and not collaborating, we now have efforts across the country to offset that confusion and chaos.”
As IDSA President, Dr. Nahass continues to advocate for vaccination policies grounded in decades of scientific data and for unified communication across the medical community to support public health and clinician decision-making.
Read the full coverage in Genetic Literacy Project